HOPE TMS ℠

HOPE-TMS℠ is Acacia's specialized accelerated TMS with genuine neuro-navigation. The targets are chosen and specifically calculated from your functional MRI scan.

5 Days

Achieve rapid relief for depression, anxiety and other personalized targets with accelerated TMS

77%

Response Rate

Personalized

Your specific brain is used to calculate and choose targets; it’s not done by generic modeling or computers. The smartest doctors are on your care.

HOPE-TMS℠ stands for Holistic, Optimized, Personalized, Expedited TMS.

Holistic

We pair the best of the best TMS protocols with a mode of psychotherapy, TEAM-CBT, that itself combines psychology best-practices to give our patients the best and most lasting results.

Optimized

TMS parameters we use are the result of decades of optimization by many research groups. We use the same machines as in the research studies.

Personalized

With HOPE-TMS℠, you get a functional MRI (or fMRI) with personalized targeting by one of the world leaders in this field, Dr. Shan Siddiqi. This is genuine and true neuronavigation to a personalized target that is unique to you. Our therapists also design a treatment course that is customized to you and your challenges.

Expedited

HOPE-TMS℠ is modeled similarly to SAINT or SNT TMS spanning 5 days with 50 stimulation sessions. You can start to feel relief from your symptoms in as little as 5 days! Acacia also values getting you the treatment fast. You should expect to receive responses within 1 business day of inquiry and see a TMS provider in as little as 3 days. Our therapy also values efficiency; we do not offer long-term therapy and expect you can make true progress within 10 sessions.

"We want depression to improve, but we don't want to leave people simply un-depressed. We want them to flourish."

— Dr. David Carreon

Media

MAY 16, 2023 — ABC7

Clinical Trial Underway Locally for Potential Breakthrough with Major Depressive Disorder

Brandon Bentzley, M.D., Ph.D., co-founder, CSO, Magnus Medical speaks with ABC7 Bay Area News about SAINT™ treatment for major depression.

NOVEMBER 7, 2021 — CBS SUNDAY MORNING

A Promising New Treatment for Depression

Depression remains the leading cause of disability worldwide, affecting almost 300 million people, half of whom can't find lasting relief from drugs or therapy. But a new experimental treatment using a fast-acting approach with targeted magnetic stimulation, called SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy), has achieved significant success in trials. Correspondent Lee Cowan reports.